| 1 |
How might using gold nanoparticles in electrochemical sensors enhance early-stage disease detection?
|
2. By increasing surface interactions for more accurate biomarker capture |
|
Gold nanoparticles provide a large surface area and excellent conductivity, which enhances the interaction between the sensor and the target biomolecules. This leads to improved capture efficiency of disease biomarkers, allowing for more sensitive and accurate detection, especially at early disease stages when biomarker concentrations are low |
Gold nanoparticles increase the electrode surface area and surface area and conductivity, facilitating enhanced biomolecular interactions and signal transduction, which are crucial for early disease biomarker detection |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following best explains how label-free electrochemical sensors support point-of-care medical diagnostics?
|
3. They provide direct measurement of target molecules with minimal preparation |
|
Label-free electrochemical sensors detect target molecules directly without needing additional labeling agents or complex preparation. This allows for simpler, faster, and more cost-effective point-of-care diagnostics, ideal for use outside specialized laboratories |
Label-free sensors offer real-time, direct detection of anyalytes without the need for external labels, facilitating rapid and convenient medical diagnostics at the point of care |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is electrochemical transduction considered advantageous over optical transduction in medical diagnostic sensors?
|
2. It is more compatible with smartphone integration for remote analysis |
|
Electrochemical transduction offers advantages like miniaturization, low power consumption, and ease of integration with portable electronics, such as smartphones. This compatibility makes it ideal for remote medical diagnostics, enabling patients and clinicians to perform and monitor tests outside traditional labs |
Electrochemical sensors are favored in point-of-care settings due to their compatibility with portable devices and ease of integration with smartphone-based platforms for remote health monitoring |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which action would most effectively increase specificity in a sensor designed to detect a single disease biomarker?
|
3. Functionalizing the electrode with disease-specific aptamers |
|
Functionalizing the electrode with disease-specific aptamers enhances sensor specificity by ensuring that only the target biomarker binds selectively to the sensor surface. Aptamers are synthetic oligonucleotides that can recognize and bind with high affinity and specificity to particular molecules, reducing cross-reactivity with unrelated substances |
The use of aptamers as bioreceptors improves sensor specificity, enabling selective binding to disease biomarkers and minimizing interference from other analytes |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
In a scenario where a sensor must detect ultra-low concentrations of a cancer biomarker, which modification is most critical?
|
3. Incorporating nanostructures to increase surface-to-volume ratio |
|
Detecting ultra-low concentrations of cancer biomarkers requires maximizing the sensor’s sensitivity. Incorporating nanostructures increased the surface-to-volume ratio, providing more active sites for biomarker binding and enhancing electron transfer, which lead to stronger and clearer signals even at low analyte concentrations |
Nanostructural materials significantly improve the sensitivity of electrochemical sensors by increasing the effective surface area and facilitating electron transfer, which is critical for detecting low-abundance biomarkers |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why might two electrochemical sensors using the same nanomaterial produce inconsistent results?
|
3. Variations in nanomaterial synthesis affect structural uniformity |
|
Even when using the same type of nanomaterial, differences in the synthesis process can lead to variations in size, shape, surface chemistry, and purity. These inconsistencies affect how the nanomaterials interact with biomolecules and transfer electrons, causing variability in sensor performance and results |
Challenges in reproducibility arise due to inconsistencies in nanomaterial fabrication, which impact the uniformity and functionality of electrochemical sensors |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which characteristic makes nanotechnology-based electrochemical sensors especially suitable for wearable medical devices?
|
3. They allow miniaturization without losing sensitivity |
|
Nanotechnology enables the creation of small, lightweight, and flexible sensors that maintain high sensitivity despite their reduced size. This makes them ideal for wearable medical devices, which require compactness without compromising performance for continuous health monitoring |
The incorporation of nanomaterials allows electrochemical sensors to be miniaturized while preserving or even enhancing sensitivity, making them well-suited for wearable applications |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What would likely happen if the bioreceptor layer is poorly immobilized on the sensor surface?
|
3. Target biomolecules may not bind effectively, leading to weak or inaccurate signals |
|
Poor immobilization of the bioreceptor layer means that the biomolecules are not firmly or uniformly attached to the sensor surface. This reduces the likelihood of effective binding between the sensor and the target analytes, leading to weak, inconsistent, or inaccurate signal outputs |
Effective immobilization of bioreceptors is critical to sensor performance; poor attachment can cause decreased sensitivity and unreliable detection results |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which modification would most directly enhance electron transfer in the sensor system?
|
2. Incorporating carbon nanotubes on the electrode surface |
|
Carbon nanotubes are known for their excellent electrical conductivity and large surface area. Incorporating carbon nanotubes on the electrode surface enhances electron transfer between the electrode and the analyte, improving sensor sensitivity and response speed |
carbon nanotubes facilitate rapid electron transfer and increase electrode conductivity, making them a popular choice for enhancing electrochemical sensor performance |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How can digital sensing technologies best support personalized cancer care?
|
2. By collecting real-time data on patient-specific symptoms and responses |
|
Digital sensing technologies enable continuous and personalized monitoring of each patient’s unique symptoms, physiological changes, and treatment responses. This real-time data collection allows clinicians to tailor treatments dynamically, improving effectiveness and minimizing side effects. This patient-centered approach contrasts with one-size-fits-all methods and supports precision oncology |
Digital sensors facilitate the continuous capture of patient-specific data, enabling personalized treatment plans that adapt to individual disease progression and therapy response |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
If a clinician needs to monitor fatigue and motion in cancer patients at home, which device should be prioritized?
|
2. Smart accelerometers in wearables |
|
Smart accelerometers integrated into wearable devices are ideal for monitoring physical activity and motion patterns, including fatigue levels, in cancer patients remotely. These sensors provide continuous, real-time data in a non-invasive manner, making them well-suited for at-home patient monitoring |
Wearable sensors equipped with accelerometers are increasingly used for monitoring patient mobility and fatigue, facilitating home-based cancer care |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why is combining sensor data with patient-reported outcomes (PROs) important in digital cancer care?
|
3. It allows a holistic understanding of patient experience |
|
Combining sensor-generated objective data with patient-reported outcomes provides a comprehensive picture of the patient's health status, including symptoms, quality of life, and treatment side effects. This integration helps clinicians better understand and address both physiological and subjective aspects of cancer care |
The integration of digital sensor metrics with patient-reported outcomes enables a more holistic assessment of treatment impact and patient well-being |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
A hospital invested in wearable digital monitoring but received low engagement from patients. Which of the following is most likely a contributing factor?
|
3. Low digital health literacy among patients |
|
Low digital health literacy can prevent patients from effectively using wearable monitoring devices or apps. Without understanding how to operate the technology or interpret data, patient engagement suffers, limiting the benefits of digital monitoring in cancer care |
patient and provider digital literacy is a key barrier to the successful adoption of digital sensing technologies in oncology |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which future trend is most aligned with the development of emerging digital cancer platforms?
|
2. Creation of pocket-sized biosensing tools integrated with smartphones |
|
The article highlights the trend toward developing compact, portable biosensing devices that can be integrated with smartphones. These tools enable real-time, point-of-care diagnostics and personalized monitoring, increasing accessibility and convenience in cancer care |
Future digital sensing platforms will focus on miniaturized, smartphone-integrated biosensors to facilitate personalized and remote cancer diagnostics |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How can real-time symptom monitoring positively affect treatment decisions?
|
3. By enabling rapid intervention before major deterioration |
|
Real-time symptom monitoring allows clinicians to detect early signs of patient decline or adverse reactions, enabling timely adjustments to treatment plans. This proactive approach helps prevent severe complications and improves patient outcomes |
Continuous digital sensing supports early identification of symptoms changes, allowing clinicians to intervene promptly and tailor treatments accordingly |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which technology is best suited to detect rare cancer biomarkers with high precision?
|
1. Digital ELISA |
|
Digital ELISA technology offers extremely high sensitivity and precision, enabling the detection of ultra-low concentrations of rare cancer biomarkers. This makes it particularly valuable for early diagnosis and monitoring of cancer |
Digital ELISA platforms provide ultrasensitive detection capabilities, essential for identifying rare biomarkers in cancer diagnostics |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Why is collaboration between data scientists and clinicians essential in digital oncology platforms?
|
3. Data insights require clinical validation for real-world use |
|
Collaboration between data scientists and clinicians ensures that the data-driven insights generated by digital oncology platforms are clinically relevant and actionable. Clinicians provide essential context and validation, bridging the gap between algorithmic predictions and patient care |
Successful implementation of digital cancer care requires interdisciplinary collaboration to translate data analytics into effective clinical decision-making |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which outcome is most likely when cancer patients actively use digital health tools to track their condition?
|
|
|
Active use of digital health tools empowers cancer patients by providing them with real-time information about their condition, enabling better communication with healthcare providers and more informed participation in treatment choices |
Patient engagment through digital monitoring fosters shared decision-making and improves overall care quality |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
A research team is developing a highly selective electrochemical sensor for detecting cancer biomarkers in blood. Based on the diagram, which combination of nanoparticle properties would most likely enhance both specificity and signal sensitivity?
|
2. Small spherical particles with antibody-conjugated targeting ligands |
|
Small spherical nanoparticles provide a high surface area and favorable surface chemistry for functionalization. When conjugated with antibody targeting ligands, these particles can selectively bind to specific cancer biomarkers, enhancing specificity. Additionally, their size and shape support efficient electron transfer and strong signal generation, improving signal sensitivity |
Functionalization of nanomaterials with biological recognition elements, such as antibodies, enables selective binding to target analytes, while the nanoscale size and shape optimize sensor sensitivity through enhanced surface interactions and electron transfer |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
A hospital is planning to adopt a single digital sensing platform to support a wide range of diagnostic applications. Based on the image, which of the following most justifies this decision?
|
2. One platform can be customized to detect toxins, cancer biomarkers, and heavy metals using interchangeable biorecognition elements |
|
Digital sensing platforms are becoming increasingly modular, meaning they can be adapted to detect multiple types of analytes, such as cancer biomarkers, environmental toxins, or heavy metals, by switching out the biorecognition element on the sensor |
An emerging trend in digital diagnostics involves the use of universal sensing platforms that can be reconfigured with interchangeable biorecognition elements. This modularity enables detection of diverse anayltes, including tumor-derived DNA, heaby metals, and bacterial toxins, on a single sensor architecture |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|